Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Pharmacokinetics

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003088-200544010-00003PMID 15634032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of uremia on pharmacokinetics and protein binding of prednisolone.

  2009influential reference
• Use of Oral Corticosteroids and Risk of Fractures

  2005cited by this paper
• Natural versus adaptive regulatory T cells.

  2005cited by this paper
• Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients

  2005cited by this paper
• Mechanisms of glucocorticoid action in bone

  2005cited by this paper
• Pulmonary hemorrhage in systemic lupus erythematosus.

  2004cited by this paper
• Effects of low-dose prednisolone on cyclosporine pharmacokinetics in liver transplant recipients: radioimmunoassay with specific and non-specific monoclonal antibodies

  2004cited by this paper
• High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response

  2004cited by this paper
• Nonlinear plasma protein binding and haemodialysis clearance of prednisolone

  2004cited by this paper
• Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin

  2004cited by this paper
• Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults

  2004cited by this paper
• Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole

  2003cited by this paper
• Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes

  2003cited by this paper
• Diversity of mechanism-based pharmacodynamic models.

  2003influential reference
• TGF-β: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

  2003cited by this paper
• CD4 cell lymphopenia and atherosclerosis in renal transplant recipients.

  2003cited by this paper
• Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation.

  2003cited by this paper
• Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.

  2003cited by this paper
• The further redefining of steroid-mediated signaling

  2003cited by this paper
• Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients

  2003cited by this paper
• Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays

  2003cited by this paper
• Pimecrolimus does not affect the differentiation, maturation and function of human monocyte‐derived dendritic cells, in contrast to corticosteroids

  2003cited by this paper
• The complementary roles of deletion and regulation in transplantation tolerance

  2003cited by this paper
• Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids

  2003cited by this paper
• The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.

  2003cited by this paper
• Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells

  2003cited by this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cited by this paper
• Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells

  2003cited by this paper
• Dexamethasone in adults with bacterial meningitis.

  2003cited by this paper
• Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications.

  2003cited by this paper
• Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response.

  2003cited by this paper
• Attenuation of glucocorticoid functions in an Anx-A1-/- cell line.

  2003cited by this paper
• What it takes to become an effector T cell: The process, the cells involved, and the mechanisms

  2003cited by this paper
• Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment

  2003cited by this paper
• Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.

  2003cited by this paper
• TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression.

  2003cited by this paper
• Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia

  2003cited by this paper
• Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning.

  2003cited by this paper
• Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics

  2003influential reference
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

  2003cited by this paper
• Changes in plasma protein binding have little clinical relevance

  2002cited by this paper
• Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action.

  2002cited by this paper
• Divergent effect of mometasone on human eosinophil and neutrophil apoptosis.

  2002cited by this paper
• Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling.

  2002cited by this paper
• CD8+ T suppressor cells are back to the game: are they players in autoimmunity?

  2002cited by this paper
• Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in man.

  2002cited by this paper
• A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression

  2002cited by this paper
• Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats

  2002cited by this paper
• Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

  2002cited by this paper
• 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.

  2002cited by this paper
• Navigating steroid hormone receptors through the nuclear compartment.

  2002cited by this paper
• Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

  2002cited by this paper
• Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids

  2002cited by this paper
• Anti-inflammatory lipid mediators and insights into the resolution of inflammation

  2002cited by this paper
• Dexamethasone in adults with bacterial meningitis.

  2002cited by this paper
• Mechanisms involved in the side effects of glucocorticoids.

  2002influential reference
• In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

  2002cited by this paper
• Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation.

  2002cited by this paper
• Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-Glycoprotein after high-dose steroid therapy

  2002influential reference
• Pharmacokinetic/pharmacodynamic studies in drug product development.

  2002cited by this paper
• What causes steroid cataracts? A review of steroid‐induced posterior subcapsular cataracts

  2002cited by this paper
• 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase.

  2002cited by this paper
• Modulation of Leukotriene B4 Receptor-1 Expression by Dexamethasone: Potential Mechanism for Enhanced Neutrophil Survival1

  2002cited by this paper
• 11β-Hydroxysteroid dehydrogenase type 1 from human liver: Dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase

  2002cited by this paper
• Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.

  2002cited by this paper
• Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

  2002cited by this paper
• Molecular mechanisms of glucocorticoid action

  2002cited by this paper
• Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

  2002influential reference
• p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.

  2002cited by this paper
• Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fractions

  2002influential reference
• 11β-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids

  2002cited by this paper
• Rapid glucocorticoid effects on immune cells.

  2002influential reference
• Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells

  2002cited by this paper
• Short‐term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone

  2002cited by this paper
• Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts

  2002cited by this paper
• Keeping up appearances

  2002cited by this paper
• Expression and activity of histone deacetylases in human asthmatic airways.

  2002cited by this paper
• Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

  2002cited by this paper
• Identification of the adrenal protease that cleaves pro-gamma-MSH: the dawning of a new era in adrenal physiology?

  2002cited by this paper
• Pharmacodynamics and Pharmacogenomics of Diverse Receptor-Mediated Effects of Methylprednisolone in Rats Using Microarray Analysis

  2002cited by this paper
• Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium.

  2002cited by this paper
• The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.

  2002cited by this paper
• Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types.

  2002cited by this paper
• Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation.

  2002cited by this paper
• The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene.

  2002cited by this paper
• A randomized, double‐blind trial of the effect of glucocorticoid, antileukotriene and bβ‐agonist treatment on IL‐10 serum levels in children with asthma

  2002cited by this paper
• Allosteric Effects of Dexamethasone and RU486 on Glucocorticoid Receptor-DNA Interactions*

  2002cited by this paper
• Stress‐Dose Corticosteroid Therapy for Sepsis and Acute Lung Injury or Acute Respiratory Distress Syndrome in Critically Ill Adults

  2002cited by this paper
• Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells

  2002cited by this paper
• Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

  2002cited by this paper
• Pathways of allorecognition: implications for transplantation tolerance.

  2002cited by this paper
• Steroids for acute spinal cord injury.

  2002cited by this paper
• Glucocorticoid regulation of proteoglycan synthesis in mesangial cells.

  2002cited by this paper
• Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers

  2002influential reference
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit

  2002cited by this paper
• Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.

  2002cited by this paper
• Expression of chemokines and chemokine receptors during human renal transplant rejection.

  2001cited by this paper
• Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages.

  2001cited by this paper
• Dexamethasone suppresses iNOS gene expression by inhibiting NF-κB in vascular smooth muscle cells

  2001cited by this paper

• Long-term in vivo pharmacokinetics of dexamethasone-loaded cochlear implant electrode carrier dummies with optimized release profiles

  2026cites this paper
• PROFILE OF INTRANASAL CORTICOSTEROIDS IN ITALY: SAFETY, COST/EFFECTIVENESS, LOCAL AND SYSTEMIC ADVERSE EFFECTS.

  2026cites this paper
• Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole‐N‐Oxide Exposure

  2026cites this paper
• Ongoing and Novel Challenges in Kidney Transplantation: Therapeutic Approaches to Non-Immunological Risk Factors for Allograft Loss.

  2026cites this paper
• Steroid-induced Behavioral Changes during Childhood and Adolescence: A Case Series of Three Patients

  2026cites this paper
• State of art of oral corticosteroids in children with acute asthma and wheezing

  2026influential citation
• Validation of a rapid and robust RP-HPLC method for quantification of triamcinolone: A unique approach for dosage and dissolution assays

  2026cites this paper
• Low-Dose Deflazacort Reduces Postoperative Pain and Inflammation Following Primary Total Knee Arthroplasty: A Randomized Controlled Trial.

  2026cites this paper
• Pulmonary delivery of low-dose dexamethasone significantly reduces toxicity in acute lung injury therapy.

  2026cites this paper
• Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders

  2026cites this paper
• Practical Considerations for the Use of Antiemetics in Pregnant Patients With Breast Cancer.

  2026cites this paper
• Research Advances in the Early Use of Hydrocortisone for Extremely/Very Preterm Infants

  2026cites this paper
• A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.

  2026cites this paper
• Solid-State Structure and Physicochemical Characterization of the Hydrocortisone–β-Cyclodextrin Inclusion Complex

  2026cites this paper
• Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer

  2026cites this paper
• Induction treatment of lupus nephritis: to pulse or not to pulse? Whether ’tis nobler to universally or selectively prescribe

  2026cites this paper
• Influence of genotype and environment on piglet vitality and metabolic state during the suckling period of divergent birth weight classes.

  2025cites this paper
• Pharmacogenetics to optimize immunosuppressant therapy in systemic lupus erythematosus: a scoping review.

  2025cites this paper
• Steroid Hormones in Pain: Mechanistic Underpinnings and Therapeutic Perspectives.

  2025cites this paper
• Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids

  2025cites this paper
• Dexamethasone chronotherapy of COVID-19 patients admitted to intensive care unit: an exploratory study

  2025cites this paper
• Eosinophilic and Mixed‐Cell Infiltration in Odontogenic Cutaneous Sinus Tracts of a Dog

  2025cites this paper
• Updated Steroid Conversion Calculator

  2025cites this paper
• Assessment of Giant Cell Arteritis–Associated Visual Outcomes at a Tertiary Hospital in Ontario, Canada

  2025cites this paper
• Neurotoxicity associated with chimeric antigen receptor T-cell therapy.

  2025cites this paper
• Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis

  2025influential citation
• Steroid Conversion Calculator (Updated 2025)

  2025cites this paper
• Glucocorticoid Treatment in Community-Acquired Pneumonia

  2025cites this paper
• Efgartigimod Combined with Glucocorticoids in the Treatment of Severe Generalized Myasthenia Gravis: A Single-Center, Retrospective Cohort Study

  2025cites this paper
• Comparison of analgesic effects between betamethasone and dexamethasone in total knee arthroplasty: a prospective randomized controlled trial

  2025cites this paper
• Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance

  2025cites this paper
• Diagnostic and prognostic utility of complete blood count-derived ratios in giant cell arteritis: a retrospective fast-track clinic cohort study

  2025cites this paper
• Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review

  2025cites this paper
• Cochlear implantation with a dexamethasone-eluting electrode array: First-in-human safety and performance results.

  2025cites this paper
• Spinal Epidural Lipomatosis, a Steroid-associated Side Effect Seen in a Case of Adult Minimal Change Disease.

  2025cites this paper
• Physiologically-Based Modeling of Methylprednisolone Pharmacokinetics Across Species with Extrapolations to Humans.

  2025cites this paper
• Design and delivery effect of prolonged-retention dexamethasone and tacrolimus microcrystals eye drops.

  2025cites this paper
• The next SABV—stress as a biological variable

  2025cites this paper
• Optimization of mononuclear cell collection material for chimeric antigen receptor T-cell therapy manufacturing: A narrative review

  2025cites this paper
• The Effect of Multiple Glycemic Parameters on Mortality and Clinical Outcomes in Critically Ill Patients in Intensive Care Unit

  2025cites this paper
• Characterization of Prednisone Degradants via Forced Degradation Studies: A UHPLC‐Based Approach With HRMS/MS, NMR, and Toxicity Predictions Using Quantitative Structure–Activity Relationship Models

  2025cites this paper
• Appropriate use and complications of corticosteroids in inflammatory bowel disease: A comprehensive review.

  2025cites this paper
• Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function

  2025cites this paper
• Comparative Effectiveness of Less vs. More Frequent Hydrocortisone Dosing in Septic Shock

  2025cites this paper
• Gene variants of glucocorticoid activation pathways and the outcomes of patients with Takayasu arteritis – a retrospective cohort study

  2025cites this paper
• Analytical and usability comparison of microsampling dried blood spot devices for glucocorticoid detection in sports using ultra-high-performance liquid chromatography-tandem mass spectrometry.

  2025cites this paper
• Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study

  2025cites this paper
• Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment

  2025cites this paper
• Use of hydrocortisone in extremely preterm infants: emphasis on those born least mature.

  2025cites this paper
• Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities

  2025cites this paper
• Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases

  2025influential citation
• Efficacy and safety of deflazacort in children with an initial episode of idiopathic nephrotic syndrome - a randomized controlled trial

  2025cites this paper
• Steroids for Pediatric Adenotonsillectomy Pain—A Prospective Multicenter Randomized Trial

  2025cites this paper
• Comparison of Relapse Rates and Time to Remission with Prednisolone Versus Deflazacort in Children with Idiopathic Nephrotic Syndrome

  2025cites this paper
• Corticosteroids and rising tide in femoral head avascular necrosis following COVID-19: A critical analysis

  2025cites this paper
• Food effects and pharmacokinetic evaluation of oral single-dose prednisone acetate and prednisolone in healthy Chinese subjects

  2025cites this paper
• Advances in Regenerative Medicine for Orthopedic Injuries: A Comprehensive Review

  2025cites this paper
• Cutting-edge treatments in amyotrophic lateral sclerosis: the role of molecular pathogenesis in targeted therapies

  2025cites this paper
• Glucocorticoids as emerging pollutants in surface water: A systematic review on their global occurrence and distribution.

  2025cites this paper
• Syndromes néphrotiques idiopathiques : prise en charge thérapeutique spécifique chez l’adulte

  2025cites this paper
• Q1 and Q2 selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation of topical generic product

  2025cites this paper
• Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits.

  2025cites this paper
• Thrombotic complications of glucocorticoids and anabolic steroids

  2025cites this paper
• Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation

  2024cites this paper
• Dangers of under‐treatment and over‐treatment with inhaled corticosteroids in children with asthma

  2024cites this paper
• Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement

  2024cites this paper
• Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids

  2024cites this paper
• Evaluating the Impact of Steroid Withdrawal on Outcomes in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

  2024cites this paper
• Hypothalamic-Pituitary-Adrenal Axis Activity and Metabolic Disorders in Kidney Transplant Recipients on Long-Term Glucocorticoid Therapy

  2024influential citation
• Cyclodextrin Inclusion Complexes with Hydrocortisone-Type Corticosteroids

  2024cites this paper
• Novel combined pharmacological strategy to alleviate acute phase response following zoledronic acid treatment

  2024cites this paper
• Molded Round Window Niche Implant as a Dexamethasone Delivery System in a Cochlear Implant-Trauma Animal Model

  2024cites this paper
• Tacrolimus Dose Requirement in De Novo Adult Kidney Transplant Patients Treated With Adoport® Can Be Anticipated

  2024cites this paper
• Perioperative Systemic Corticosteroids in Modern Total Hip and Knee Arthroplasty

  2024cites this paper
• Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects

  2024cites this paper
• The glucocorticoid dose-mortality nexus in pneumonia patients: unveiling the threshold effect

  2024cites this paper
• Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology.

  2024cites this paper
• A Retrospective Data Audit of Outcome of Moderate and Severe Covid-19 Patients Who Had Received MP and Dex: A Single Center Study

  2024cites this paper
• Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis

  2024cites this paper
• Corticosteroids for the treatment of Duchenne muscular dystrophy: a safety review

  2024cites this paper
• A systematic review of steroid use in peripheral nerve pathologies and treatment

  2024cites this paper
• Visual recovery after oral high-dose methylprednisolone in acute inflammatory optic neuropathy

  2024cites this paper
• Understanding the Ocular Hypertension Model in Mice Induced by Dexamethasone-21-Acetate – Implications for Glaucoma Research

  2024cites this paper
• CYP3A4 Poor and Intermediate Metabolizers Have a Higher Rate of Steroid-Induced Intraocular Pressure Response

  2024cites this paper
• Immune response caused by M1 macrophages elicits atrial fibrillation-like phenotypes in coculture model with isogenic hiPSC-derived cardiomyocytes

  2024cites this paper
• Budesonide in Liver Immunology: A Therapeutic Opportunity in Liver Transplantation

  2024cites this paper
• Safely Withdrawing Glucocorticoid Therapy: A Case-Based Approach

  2024cites this paper
• Diagnostic Challenges in Neuro-Psychiatric Systemic Lupus Erythematosus: A Case of a Patient With Psychosis Secondary to Lupus Cerebritis in the Setting of a Steroid Taper

  2024cites this paper
• Prospects for adjuvant therapy with systemic corticosteroids for community-acquired pneumonia: from experiment to clinical practice

  2024cites this paper
• Herbal and Non-Herbal Dietary Supplements for Psychiatric Indications: Considerations in Liver Transplantation

  2024cites this paper
• Intermittent pulses of methylprednisolone with low-dose prednisone attenuate lupus symptoms in B6.MRL-Faslpr/J mice with fewer glucocorticoid side effects.

  2024cites this paper
• Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit

  2024cites this paper
• Investigating drug-gut microbiota interactions: Reductive and hydrolytic metabolism of oral glucocorticoids by in vitro artificial gut microbiota.

  2024cites this paper
• Investigation of the Efficacy of Bevacizumab Treatment in An Experimental Rat Model of Chronic Subdural Hematoma.

  2024cites this paper
• European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency

  2024cites this paper
• The Unprecedented Success of Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Hematological Malignancies

  2024cites this paper
• Intraoperative Dexamethasone is associated with a lower risk of respiratory failure in Thoracic Surgery: Observational cohort study (SURTHODEX).

  2024cites this paper
• European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.

  2024cites this paper
• Methylprednisolone alone or combined with cyclosporine or mycophenolate mofetil for the treatment of immune‐mediated hemolytic anemia in dogs, a prospective study

  2024cites this paper
• A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease.

  2024cites this paper